Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
CAH Stock Chart & Stats
$227.18
-$0.20(-0.16%)
At close: 4:00 PM EST
$227.18
-$0.20(-0.16%)
Day’s Range― - ―
52-Week Range$120.72 - $229.76
Previous CloseN/A
Volume818.36K
Average Volume (3M)1.42M
Market Cap
$49.15B
Enterprise Value$60.23B
Total Cash (Recent Filing)$2.78B
Total Debt (Recent Filing)$9.03B
Price to Earnings (P/E)29.8
Beta0.35
Next Earnings
Apr 30, 2026EPS Estimate
2.75Next Dividend Ex-DateN/A
Dividend Yield0.98%
Share Statistics
EPS (TTM)2.63
Shares Outstanding237,595,050
10 Day Avg. Volume1,815,220
30 Day Avg. Volume1,423,306
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)-14.56
Price to Sales (P/S)0.18
P/FCF Ratio21.89
Enterprise Value/Market Cap1.23
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit6.80
Enterprise Value/Ebitda18.64
Forecast
1Y Price Target
$247.42Price Target Upside8.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Earnings GuidanceRaised FY26 EPS guidance signals management's confidence in sustained earnings growth and supports a higher valuation multiple for Cardinal Health.
MSO Platform ExpansionAcquisition of Solaris Health broadens Cardinal Health's MSO platform to around 3,000 providers across 32 states, strengthening recurring service revenues and contributing to EBIT growth.
Specialty Business GrowthExpansion in Specialty operations, led by specialty medicines, is delivering double-digit growth that can drive margin improvement and lift core profitability.
Bears Say
Capital Allocation And DilutionHigher expected share count from buyback pricing could dilute EPS and offset operational earnings gains, reducing net benefit to shareholders.
Guidance ConservatismConservative FY26 guidance may constrain investor expectations and keep the stock from fully reflecting potential upside if performance surpasses management estimates.
Cardinal Health News
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $120.72 and its highest was $229.76 in the past 12 months.
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $49.15B.
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is Apr 30, 2026 which is in 83 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Feb 05, 2026. The company reported $2.63 earnings per share for the quarter, beating the consensus estimate of $2.341 by $0.289.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Quarterly dividend of $0.511 which represents an annual dividend yield of 0.98%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is 2.75.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 237,595,050 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $2.63 in its last earnings report, beating expectations of $2.341. Following the earnings report the stock price went up 9.828%.
Which hedge fund is a major shareholder of Cardinal Health?
Currently, no hedge funds are holding shares in CAH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cardinal Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$247.42 (8.91% Upside)
$247.42 (8.91% Upside)
Blogger Sentiment
Bullish
CAH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 560.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 1.3%
Last 30 Days ▲ 1.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.32%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
28.26%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
CAH Company Deck
CAH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated broad-based, strong operational and financial performance across segments with multiple upward guidance revisions (notably EPS and pharma profit), robust revenue and profit growth, and improved leverage and cash generation. Most negatives were transitory or tied to known acquisition and macro headwinds (interest costs, tariffs, timing-related GNPD inventory effects) that management is actively addressing. Given the weight and scale of positive results, guidance raises, and clear momentum in specialty and other growth businesses, positives substantially outweigh the negatives.View all CAH earnings summariesCAH Revenue Breakdown
91.94% Pharmaceutical and Specialty Solutions
5.68% Global Medical Products and Distribution
2.42% Other
-0.04% Corporate
CAH Stock 12 Month Forecast
Average Price Target
$247.42
▲(8.91% Upside)
Technical Analysis
Ownership Overview
0.24% Insiders
23.05% Mutual Funds
0.30% Other Institutional Investors
48.41% Public Companies and Individual Investors